Laura Seclì

5PUBLICATIONS
18CO-AUTHORS
Molecular targetsInnate immunityMedical devicesEnvironmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 30, 2025
Neoadjuvant personalized viral vaccine prevents tumor relapse in checkpoint-resistant murine melanoma model.

Laura Seclì, Linda Nocchi, Guido Leoni

|Feb 08, 2024
Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine.

Irene Garzia, Linda Nocchi, Lidia Avalle

|Dec 09, 2023
Personalized Cancer Vaccines Go Viral: Viral Vectors in the Era of Personalized Immunotherapy of Cancer.

Laura Seclì, Guido Leoni, Valentino Ruzza

|Apr 28, 2023
Vector Aided Microenvironment programming (VAMP): reprogramming the TME with MVA virus expressing IL-12 for effective antitumor activity.

Laura Seclì, Luigia Infante, Linda Nocchi

|Feb 05, 2021
The dark-side of the outside: how extracellular heat shock proteins promote cancer.

Laura Seclì, Federica Fusella, Lidia Avalle

Pageof 1